Jennissen Herbert P
Institute of Physiological Chemistry, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
Front Bioeng Biotechnol. 2023 Sep 7;11:1226649. doi: 10.3389/fbioe.2023.1226649. eCollection 2023.
The constant release of human bone morphogenetic protein 2 (rhBMP-2) in the picomolar range (Pico-Stat) from PDLLA-biohybrids led to the detection of intrinsic novel pro- and anti-angiogenic functions of this cytokine. As integrant part in this perspective of previous work, first evidence for the binding of rhBMP-2, as an , to allosteric angiogenic receptors in cocultures of human endothelial cells is reported.
聚乳酸-生物杂交体以皮摩尔范围(皮克-Stat)持续释放人骨形态发生蛋白2(rhBMP-2),从而检测到这种细胞因子内在的新型促血管生成和抗血管生成功能。作为先前工作这一观点的组成部分,本文报道了rhBMP-2作为一种[此处英文缺失]与人类内皮细胞共培养中的变构血管生成受体结合的首个证据。